A Historic Celebration, the 93rd Anniversary of the Hidalgo-Starr Counties Medical Society Alliance

Publisher's Picks
435

Translate to Spanish or other 102 languages!

Mega Doctor News –

- Advertisement -

By Roberto Hugo Gonzalez,

The Hidalgo-Starr Counties Medical Society Alliance was founded in 1923 by a group of physician spouses of Hidalgo County, who wanted to help the community and support medicine.

Ninety-three years later, using the same venue of their first meeting, Dr. Jake Margo welcomed everyone to the event. He said “My name is Dr. Javier “Jake” Margo, Jr., I’m the current president of the Hidalgo-Starr County Medical Society.” He continued, “This is the 93rd Anniversary of the very first meeting of our society in this great hotel.” The meeting took place at the Casa de Palmas Hotel on Main Street built in 1918.

- Advertisement -

[diamond_book cat=’hidalgo-starr-county-medical-society’]

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
DHR To Host 11th Annual “Fishing For Hope” Tournament
Next article
McAllen International Airport flies nonstop to Mexico, Las Vegas, Orlando and Los Angeles.

More Articles

DHR Health Raises Over $520K at 20th “Fishing for Hope” Event

DHR Health made a big splash at the 20th Annual “Fishing for Hope” Tournament, held on August 22 at Jim’s Pier in South Padre Island, raising an impressive grand total of $524,130.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 

STHS Behavioral Marks Suicide Prevention Month with Community Chalk Event

Every 11 minutes, someone in the United States dies by suicide, according to the Centers for Disease Control and Prevention (CDC), making it one of the nation's leading causes of death.

Moderna and Merck Report Positive Phase 3 Results for Personalized Cancer Therapy

Moderna and Merck have reached a major clinical milestone after their investigational individualized cancer therapy, combined with Merck’s Keytruda, produced positive results in a Phase 3 study involving patients with high-risk melanoma.
- Advertisement -